Genelux Corporation
Clinical trials sponsored by Genelux Corporation, explained in plain language.
-
Cancer-Fighting virus plus chemo and immunotherapy takes on lung cancer in new trial
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease got worse after initial treatment. It combines an injected virus (Olvi-Vec) that targets cancer cells, followed by chemotherapy and an immunotherapy drug, and compares it to standard chemotherapy a…
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 18, 2026 11:53 UTC
-
Virus therapy shows promise against tough ovarian cancer in new trial
Disease control Recruiting nowThis study tests a new treatment called Olvi-Vec, a virus that targets cancer cells, followed by standard chemotherapy and bevacizumab, in women with ovarian cancer that no longer responds to platinum-based drugs. About 186 participants will receive either the virus combination o…
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC